(Q39582097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

meta-analysis

0 references

title

Statin use and risk of Parkinson's disease: a meta-analysis of observational studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Kapil Gudala

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Swathi Malla

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dipika Bansal

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

21 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

158-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22820685%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-012-6606-3

8 February 2020

exact match

0 references

cites work

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Epidemiology and etiology of Parkinson's disease: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Statins and neuroprotection: a prescription to move the field forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Statins: multiple neuroprotective mechanisms in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Statin use and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Statin use and Parkinson's disease in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Prospective study of statin use and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Inflammation as a causative factor in the aetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6606-3

Protective effect of fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on MPP(+)-induced hydroxyl radical in the rat striatum

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Statins and the risk of Parkinson disease: an update on the controversy

1 reference

PubMed

12 December 2020

Etiology of Parkinson's disease

1 reference

PubMed

12 December 2020